| |
|
|
|
Sutro Biopharma Inc  
|
|
19.64 -0.65 (-0.03%) |
03-05 11:57 |
|
Open: |
20.4 |
Pre close: |
20.29 |
Target:
|
28.97 
|
|
High: |
20.45 |
Low: |
19.145 |
Resistance:
|
24.80
28.30
|
|
Volume: |
288,265 |
Market Cap: |
896M |
Support:
|
19.15
15.93
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
21.32
|
MACD |
MACD(12,26):
|
-0.90 |
|
MA(20): |
23.31 |
Signal(12,26,9): |
-0.49 |
|
MA(100): |
20.17  |
Stochastic Oscillator |
%K(14,3):
|
7.26 |
|
MA(250): |
13.77 |
%D(3): |
12.37 |
|
Average Volume(K) |
3-Month: |
57300
|
52-Week |
High:
|
28.30 |
|
10-Days: |
42365 |
Low: |
6.00 |
|
RSI |
RSI(14):
|
35.33 |
Change(%): |
127.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.440 |
Return on Equity (ttm) |
7.1 |
Shares Out. (M) |
45.61 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.0 |
Shares Float (M) |
29.04 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.11 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
45.2 |
% Held by Institutions |
88.44 |
|
Forward EPS |
-2.430 |
Gross Profit (p.s.) |
-0.502 |
Shares Short (K) |
1140 |
|
Book Value (p.s.) |
6.410 |
EBITDA (p.s.) |
-1.246 |
P/E |
44.68 |
|
Sales Per Share |
1.003 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.07 |
|
Profit Margin |
27.60 |
Operating Cash Flow
(M) |
-62.08 |
P/S |
19.60 |
|
Operating Margin |
-133.66 |
Levered Free Cash Flow
(M) |
-31.55 |
P/CF |
-14.44 |
|
|
|
|
|
|
